Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| 1 |
Microsoft
MSFT
|
+$775M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$508M |
| 3 |
Amazon
AMZN
|
+$497M |
| 4 |
Meta Platforms (Facebook)
META
|
+$430M |
| 5 |
Costco
COST
|
+$345M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
+$325M |
| 2 |
Deutsche Bank
DB
|
+$310M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$292M |
| 4 |
Pfizer
PFE
|
+$266M |
| 5 |
Apple
AAPL
|
+$254M |
Sector Composition
| 1 | Technology | 26.73% |
| 2 | Healthcare | 13.88% |
| 3 | Financials | 11.82% |
| 4 | Communication Services | 9% |
| 5 | Consumer Discretionary | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Y-mAbs Therapeutics
YMAB
$390M
| $303K | ﹤0.01% |
18,639
-25
| -0.1% | -$407 |
|
2527
Heidrick & Struggles
HSII
$1.03B
| $303K | ﹤0.01% |
8,999
+25
| +0.3% | +$841 |
|
|
UHT
2528
Universal Health Realty Income Trust
UHT
$575M
| $303K | ﹤0.01% |
8,246
-2,804
| -25% | -$103K |
|
2529
Travel + Leisure Co
TNL
$4.02B
| $302K | ﹤0.01% |
6,172
+447
| +8% | +$21.9K |
|
2530
3D Systems Corporation
DDD
$286M
| $302K | ﹤0.01% |
68,031
+10,050
| +17% | +$44.6K |
|
2531
Cerence
CRNC
$450M
| $302K | ﹤0.01% |
19,160
-70,059
| -79% | -$1.1M |
|
2532
SPDR Dow Jones REIT ETF
RWR
$1.88B
| $302K | ﹤0.01% |
3,200
| – | – |
|
2533
First Mid Bancshares
FMBH
$945M
| $301K | ﹤0.01% |
9,200
+133
| +1% | +$4.35K |
|
2534
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $300K | ﹤0.01% |
125,513
-1,006,726
| -89% | -$2.41M |
|
2535
Xometry
XMTR
$2.59B
| $299K | ﹤0.01% |
17,728
+442
| +3% | +$7.47K |
|
|
CFB
2536
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $299K | ﹤0.01% |
21,590
-5,298
| -20% | -$73.3K |
|
2537
Calavo Growers
CVGW
$489M
| $298K | ﹤0.01% |
10,717
+95
| +0.9% | +$2.64K |
|
2538
V2X
VVX
$1.7B
| $298K | ﹤0.01% |
6,374
+357
| +6% | +$16.7K |
|
2539
Olympic Steel
ZEUS
$368M
| $297K | ﹤0.01% |
4,197
+266
| +7% | +$18.9K |
|
2540
Summit Therapeutics
SMMT
$14.1B
| $296K | ﹤0.01% |
71,526
-1,711
| -2% | -$7.08K |
|
2541
iShares New York Muni Bond ETF
NYF
$921M
| $296K | ﹤0.01% |
5,500
-750
| -12% | -$40.4K |
|
2542
Beyond Meat
BYND
$205M
| $294K | ﹤0.01% |
35,449
+4,653
| +15% | +$38.5K |
|
2543
Fate Therapeutics
FATE
$111M
| $293K | ﹤0.01% |
39,982
+2,157
| +6% | +$15.8K |
|
2544
iShares MSCI Emerging Markets ex China ETF
EMXC
$13.1B
| $293K | ﹤0.01% |
5,097
-1,668
| -25% | -$96K |
|
2545
RPC Inc
RES
$986M
| $293K | ﹤0.01% |
37,859
-120,291
| -76% | -$931K |
|
|
EGLE
2546
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $293K | ﹤0.01% |
4,690
+88
| +2% | +$5.5K |
|
2547
Vanguard Small-Cap Growth ETF
VBK
$20.5B
| $293K | ﹤0.01% |
1,123
| – | – |
|
2548
Old Second Bancorp
OSBC
$961M
| $292K | ﹤0.01% |
21,075
+4,146
| +24% | +$57.4K |
|
2549
United States Lime & Minerals
USLM
$3.63B
| $291K | ﹤0.01% |
4,880
| – | – |
|
2550
CureVac
CVAC
$1.2B
| $291K | ﹤0.01% |
95,993
+25,372
| +36% | +$76.9K |
|